← FDA Drug Approvals (Drugs@FDA)
ESLICARBAZEPINE ACETATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2024-03-27
Drug application
- FDA Application #
ANDA211246- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ESLICARBAZEPINE ACETATE
- Generic name
- ESLICARBAZEPINE ACETATE
- Active ingredients
- ESLICARBAZEPINE ACETATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- LUPIN
- Manufacturer
- Lupin Pharmaceuticals, Inc.
- First approval
- 2024-03-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown